The ruling allows generic drugmakers to challenge the original legality of expired patents, potentially shielding them from past damage claims and speeding up the arrival of affordable medicines.
​The ruling allows generic drugmakers to challenge the original legality of expired patents, potentially shielding them from past damage claims and speeding up the arrival of affordable medicines. by Soban News (international And National News)
